Oman vs Turkmenistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Oman
99.0%
in 2025
Turkmenistan
99.0%
in 2025
Oman rank
1st
Turkmenistan rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Oman
- Turkmenistan
How they compare
Oman currently reports 99.0% against 99.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Oman ahead.
Oman ranks 1st and Turkmenistan ranks 1st of 194 countries.
Across the 3 decades both report, Oman averaged higher in 1 and Turkmenistan in 1.
Head to head by decade
| Decade | Oman | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.8% | 94.5% | 3.3% | Oman |
| 2010s | 98.9% | 99.0% | 0.1% | Turkmenistan |
| 2020s | 98.8% | 98.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Oman or Turkmenistan?
- Oman, at 99.0% against 99.0% in Turkmenistan as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Oman and Turkmenistan?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Turkmenistan?
- 26 years are reported by both, from 2000 to 2025.
- How do Oman and Turkmenistan rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Oman ranks 1st and Turkmenistan ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.